Hi Hottod, thanks as always for your insights, did you perhaps mention something about this Extension Study of Pimavanserin in Irritability Associated with Autism Spectrum Disorder that was stopped for business reasons and not safety concerns? It would be interesting to know more
https://clinicaltrials.gov/study/NCT05555615
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.48 |
Change
0.000(0.00%) |
Mkt cap ! $2.076B | |||
| Open | High | Low | Value | Volume |
| $16.48 | $16.77 | $16.28 | $3.108M | 188.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 105 | $16.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.54 | 885 | 2 |
View Market Depth
| Last trade - 16.13pm 28/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |